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In hyperthyroid chicks, oestrogen-induced plasma accumulation of riboflavin-binding
protein was diminished, whereas the reverse situation prevailed in hypothyroid birds.
Under hyperthyroid conditions, higher concentrations of oestrogen were required to elicit
a response comparable with that obtained in normal birds treated with lower concen-
trations of the hormone. Elevated hepatic cytochromeP450 concentrations and decreased
half-life of the induced protein in hyperthyroid animals suggest that higher catabolic rates
of the inducer and induced protein are contributory factors to the diminished response.
The reciprocal interaction between oestrogen and
the thyroid hormones at the level of metabolism and/
or growth and function of target tissue is well docu-
mented. This is exemplified by (a) the counteraction
of oestrogen-induced adenohypophysial and thyroid
hypertrophy by thyroxine (Schriber, 1971; Yamada
et al., 1966), (b) the enhanced peripheral metabolism
of the thyroid hormones after the administration of
steroid hormones (Galton, 1971) and (c) altered
uterine sensitivity to oestrogen in hyperthyroid and
hypothyroid animals (Ruh et al., 1970a,b). The
findings that oestrogen induced elevated concen-
trations of serum alkaline phosphatase and Ca2+ in
laying hens (Snapir & Perek, 1970) and that biotin,
riboflavin and vitamin A concentrations (and hepatic
hypertrophy) in immature female chicks (Common et
al., 1949; Mooyoung et al., 1960) are severely cur-
tailed under hyperthyroid conditions suggest that the
thyroid status of an animal can influence the steroid-
hormone-induced specific biochemical responses.
However, the mechanisms involved have remained
largely unexplored.
The chicken liver, besides being a target tissue for
oestrogen in terms of induction of specific yolk
proteins (Gruber et al., 1976), is also a major cata-
bolic site for the steroid, and thus represents an
attractive model system for exploration of the bio-
chemical basis of oestrogen-thyroid-hormone inter-
action. Riboflavin-binding protein is a yolk protein
that is specifically induced after oestrogen treatment
(U. S. Murthy & P. R. Adiga, unpublished work).
The present communication deals with the modu-
lation of induction of this specific protein under
hyperthyroid and hypothyroid conditions and the
underlying mechanisms.
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Materials and MIethods
Oestradiol-17,8, L-thyroxine, propylthiouracil and
sodium cholate were products ofSigma Chemical Co.,
St. Louis, MO, U.S.A. Na 1251 for protein iodination
was procured from The Radiochemical Centre,
Amersham, Bucks., U.K. The sources of other
chemicals have been listed elsewhere (Murthy &
Adiga, 1977).
Hypothyroidandhyperthyroidconditions and induction
ofriboflavin-binding protein
White Leghorn male chicks (2 months old;
0.4-0.5kg body wt.) obtained from the Central
Poultry Farm, Hesserghatta, Bangalore, India, were
maintained in individual cages and fed on a com-
mercial diet and water ad libitum. They received six
daily intraperitoneal injections of either L-thyroxine
(100,pg/kg) in saline (hyperthyroid) or propyl-
thiouracil (100mg/kg) in 0.5 % (w/v) gelatin in saline
(hypothyroid). The control birds received saline
(0.9% NaCI) only. After 6 days, a single dose of
oestradiol-17fi/propane-1,2-diol was administered
intramuscularly to individual birds at the indicated
doses (see the legends to Tables 1 and 2). Blood
(0.5ml) was withdrawn at specified times by cardiac
puncture, plasma prepared and theriboflavin-binding-
protein content was measured by the sensitive radio-
immunoassay procedure (Murthy & Adiga, 1977).
Half-life ofriboflavin-binding protein
Highly purified egg-white riboflavin-binding pro-
tein (Murthy & Adiga, 1977) was radioiodinated with
Na125I by the method of Greenwood et al. (1963),
purified by gel filtration on Sephadex G-25, and
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diluted with unlabelled riboflavin-binding protein to a
final concentration of 1 mg/ml in saline. It was
then administered by the intracardiac route to the con-
trol and the hyperthyroid birds. Blood samples were
withdrawn at 1 h intervals, and plasma was prepared
and its radioactivity counted in an Autogamma
counter (Packard Autogamma Counter, model 2002).
Samples (0.2 ml) of the plasma were treated with
1: 50-diluted specific rabbit antiserum to riboflavin-
binding protein (Murthy et al., 1976) at 37°C for 6h,
and 0.2ml of double antibody (goat antiserum to
rabbit immunoglobulin) was added to each to precipi-
tate 1251-labelled riboflavin-binding protein-rabbit
antibody complex (Murthy & Adiga, 1977). The
radioactivity in the precipitate was counted and was
invariably found to represent 80% of total blood
radioactivity. This procedure established that a major
and constant proportion of blood radioactivity
represented that due to circulating 1251-labelled
riboflavin-binding protein. The half-life of the protein
was computed from the rate of disappearance of the
labelled protein from the circulation (McFarlane,
1964).
Determination ofhepatic cytochrome P450
The low content ofcytochrome P-450 in this system
(Kulkarni et al., 1976) necessitated the solubilization
of the microsomal fraction (Lu & Levin, 1972). A
5-10-fold higher concentration of the protein could
thus be used for the assay. A 5 % (w/v) homogenate
of liver (3 g) in ice-cold 1.15 % (w/v) KCl was spun at
20000g for 30min at 4°C and the microsomal fraction
was sedimented from this postmitochondrial super-
natant in a Beckman/Spinco model L-3 ultra-
centrifuge (14000O0g for 60min). The microsomal
pellet was suspended in 3 ml of 0.1 M-potassium
phosphate buffer, pH7.6, containing 20% (v/v)
glycerol, 1 mM-EDTA and 1 mM-dithiothreitol, then
sonicated twice (6mA for 30 s; Branson Sonifier
model S75), and the suspension was clarified by
adding sodium cholate to the final concentration of
1 % (w/v). The cytochrome P-450 was assayed as
detailed by Omura & Sato (1964). Protein concen-
tration in these preparations was measured by the
method of Lowry et al. (1951), with crystalline bovine
serum albumin as the standard.
Results and Discussion
The kinetics of elaboration of riboflavin-binding
protein in male chicks as reflected by the plasma
concentration of the protein in response to a single
injection of oestradiol-17f show that, after an initial
4h lag phase, the concentration of the protein in-
creases severalfold by 24h, reaching peak values
around 48h, declining in a symmetrical fashion
thereafter (U.S. Murthy & P. R. Adiga, unpublished
work). Further, this pattern was not qualitatively
influenced by the thyroid status ofthe birds. However,
the data in Table 1 clearly show that quantitatively
both hypothyroid and hyperthyroid conditions
profoundly influence the extent of accumulation of
riboflavin-binding protein in the blood, and this
phenomenon is evident during both ascending (24h)
and descending (72h) phases of the induction
process. Whereas chronic thyroxine treatment drasti-
cally diminished the accumulation of riboflavin-
binding protein to approx. 40% of that in chicks
treated with oestrogen alone, the reverse situation
prevailed when propylthiouracil interfered with endo-
genous thyroid-hormone production. Since all the
circulating riboflavin in oestrogenized chicks is bound
to the riboflavin-binding protein (U. S. Murthy &
P. R. Adiga, unpublished work), the earlier findings
(Common et al., 1949) that oestrogen-enhanced
plasma riboflavin content is curtailed by thyroxine
treatment can be explained as being primarily due to
decreased content of the binding protein, rather than
to exclusive interference with metabolism of the
vitamin as such.
Among the possible underlying mechanisms, it was
considered that the diminished response to oestrogen
under hyperthyroid conditions could be due to an
accelerated metabolic clearance rate of the steroid
with a resultant decrease in effective concentration of
the inducer at the site of its action, namely the liver.
The validity ofthis premise is supported by the finding
that increasing the dose of oestradiol to 20mg/kg
body wt. in hyperthyroid birds elicited a response
comparable with that obtained with 10mg of
oestrogen/kg body wt. in control chicks (Table 1).
Table 1. Influence of hypothyroidism and hyperthyroidism
on oestrogen-induced plasma concentrations of riboflavin-
binding protein in male chicks
Experimental details are given in the text. Preinjection
control values are means of those obtained with nine
chicks. Chronic treatment with thyroxine or
propylthiouracil did not alter the baseline values.
Experimental values are means±s.D. for four chicks.
Plasma concentration of
riboflavin-binding protein
(ng/mil)
Treatment
(mg/kg body wt.)
None (control)
Oestrogen (10)
Propylthiouracil (100)
+oestrogen (10)
Thyroxine (0.1)
+oestrogen (10)
Thyroxine (0.1)
+oestrogen (20)
At 24h At 72h
21
920±129 650±10
1466±139* 925±75*
316±47* 186±20*
946±158 690±75
* Values significantly different from those obtained with
oestrogen treatment alone at P < 0.01.
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Pertinent in this connexion is the observation by
Vonhorn (1933) that in hyperthyroid ovariectomized
rats higher amounts of oestrogen were needed to
produce a positive oestrus vaginal smear. Also con-
sistent with our finding are the data of Ruh et al.
(1970a,b), showing that the uterine uptake and
retention of [3H]oestradiol as well as weight response
were higher in hypothyroid and diminished in
hyperthyroid rats.
A higher rate of oestradiol catabolism, especially to
its hydroxylated products, in hyperthyroid humans
has been well established (Gallagher et al., 1966).
Furthermore steroid hydroxylation proceeds prefer-
entially through the mixed-function oxidase system
in which cytochrome P-450 occupies a central
position (Kuntzman et al., 1965), andtherefore micro-
somal cytochrome P450 concentrations should
represent a sensitive index of the catabolic rate of
oestradiol (Kappas & Song, 1969). The data in Table 2
clearly show that oestradiol administration leads to
marked increase in the hepatic cytochrome P450
content measured at 24h. This is in agreement with the
extensive proliferation of smooth (as well as rough)
endoplasmic reticulum (the cellular locus of cyto-
chrome P450) that has been noticed in chickens
treated with the steroid hormone (Schjeide et al.,
1974). Of interest in this context is the observation
(Levin et al., 1967) that chronic phenobarbitone
treatment of rats, resulting in enhanced hepatic cyto-
chrome P-450 concentrations, led to a markedly
diminished response to oestrogen in terms of the
production of uterine hypertrophy. More specifically,
chronic thyroxine treatment augmented these con-
centrations further, in good agreement with the
Table 2. Influence of oestrogen and thyroxine on hepatic
cytochrome P450 content in male chicks
Experimental details are given in the text. In the
combined treatment, thyroxine was injected daily for
6 days before oestrogen; then 24h after a single
injection of oestrogen the content of cytochrome
P-450 was determined. Values are means+s.D. for
three chicks.
Treatment
(mg/kg body wt.)
None (control)
Oestrogen (10)
Thyroxine (0. 1)
Thyroxine (0. 1)
+oestrogen (10)
Cytochrome P-450 content
(nmol/mg of microsomal protein)
0.179±0.023
0.247±0.042*
0.297+0.061t
0.455±0.03t
* Value significantly different from the control at
P < 0.05.
t Value significantly different from the control at
P < 0.02.
t Value significantly different from the control at
P < 0.001 and from that obtained with thyroxine alone or
oestrogen alone at P < 0.01.
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Fig. 1. Time course of disappearance of '25I-labelled
riboflavin-binding protein from the plasma ofuntreated and
thyroxine-treated mate chicks
Freshly '251-labelled riboflavin-binding protein (1 mg;
4x 106c.p.m./chick) was injected into 2-month-old
untreated birds (0) or thyroxine-treated birds (o) by
the cardiac route. Oestrogen administration by itself
had no influence on the half-life of exogenously
administered riboflavin-binding protein in control
and thyroxine-treated birds. Radioactivity in the
plasma was measured at h intervals. Each point
represents the means±s.D. of three to six chicks.
accelerated catabolism of oestradiol in hyperthyroid-
ism suggested above. Thyroxine treatment in itself
increased the cytochrome P-450 concentration
significantly, and this may be related to increased
utilization ofendogenous substrates by the liver ofthe
hyperthyroid birds.
Since the extent of accumulation of riboflavin-
binding protein in the blood is determined by the
relative rates of synthesis and degradation, it was
considered that an additional contributory factor for
decreased concentration of the protein in hyper-
thyroidism might be related to enhanced turnover
rate of the induced protein. This was sought to be
established by comparing the half-life of the exo-
genously administered 125I-labelled protein in control
and thyroxine-treated birds. Fig. 1 shows that in the
normal or oestrogen-treated birds the t* of riboflavin-
binding protein is about 10 h, whereas it is only 6h in
hyperthyroid chicks. Although perfusion studies with
isolated rat liver have shown (Griffin & Miller, 1973)
that the synthetic rates of different normal plasma
proteins are differentially affected by thyroxine, to
our knowledge the present data represent the first
demonstration of the thyroid hormone drastically
shortening the turnover rate of an oestrogen-induced
specific protein.
From the foregoing, it is clear that enhanced cata-
bolism of both the inducer and the induced protein
are contributory mechanisms underlying the modu-
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lation of oestrogenic response by the thyroid
hormones. Yet another additional factor envisaged
is the thyroid-hormone-influenced alteration in the
sensitivity of the target tissue to oestrogen (Meites &
Chandrashekar, 1949; Ruh et al., 1970a), and this
awaits further study.
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